Assignee profile:

Otsuka Pharmaceutical Co., Ltd.

City:

Osaka

Country:

Japan

Published Applications:

19

Last publication date:

2026-05-14

Patent Grants:

8

Last grant date:

2017-01-10

Top Inventors for applications by Otsuka Pharmaceutical Co., Ltd.

These are the the leading inventors for applications assigned to Otsuka Pharmaceutical Co., Ltd.:

Recent patent applications by Otsuka Pharmaceutical Co., Ltd.

Otsuka Pharmaceutical Co., Ltd. based in Osaka, JP has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-05-14
US20260130904A1
Human necessities

PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS

#2 | 2023-03-30
US20230099694A1
Human necessities

PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS

#3 | 2021-02-25
US20210052575A1
Human necessities

PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS

#4 | 2020-02-27
US20200061056A1
Human necessities

PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS

#5 | 2019-06-06
US20190167672A1
Human necessities

PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS

#6 | 2018-11-08
US20180318294A1
Human necessities

PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS

#7 | 2018-04-05
US20180092907A1
Human necessities

PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS

#8 | 2017-06-01
US20170151237A1
Human necessities

PHARMACEUTICAL PREPARATION COMPRISING BREXPIPRAZOLE AND SUBSTITUTED BETA-CYCLODEXTRIN

#9 | 2017-03-23
US20170082620A1
Physics

C1q-ADIPONECTIN COMPLEX AND USE THEREOF

#10 | 2017-03-16
US20170071933A1
Human necessities

PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS

#11 | 2016-05-26 ✅ Patent 9,539,252 granted on 2017-01-10
US20160143905A1
Human necessities

Piperazine-substituted benzothiophene derivatives as antipsychotic agents

#12 | 2014-10-23 ✅ Patent 9,206,429 granted on 2015-12-08
US20140315986A1
Chemistry; metallurgy

Aptamers that bind to IL-6 and their use in treating or diagnosing IL-6 mediated conditions

#13 | 2014-01-23 ✅ Patent 8,785,386 granted on 2014-07-22
US20140024640A1
Chemistry; metallurgy

Benzazepine derivatives useful as vasopressin antagonists

#14 | 2013-06-13 ✅ Patent 8,669,088 granted on 2014-03-11
US20130150568A1
Chemistry; metallurgy

Enzyme associated with equol synthesis

#15 | 2013-03-14 ✅ Patent 8,993,014 granted on 2015-03-31
US20130066084A1
Human necessities

Equol-containing extract, method for production thereof, method for extraction of equol, and equol-containing food

#16 | 2010-09-30 ✅ Patent 8,372,830 granted on 2013-02-12
US20100249104A1
Human necessities

Methods for using vasopressin antagonists with anthracycline chemotherapy agents to reduce cardiotoxicity and/or improve survival

#17 | 2008-10-07 ✅ Patent 7,432,363 granted on 2008-10-07
US10743018
-

Ly6H gene

#18 | 2008-09-11
US20080221084A1
Human necessities

METHOD FOR REDUCING INFARCTION USING VASOPRESSIN ANTAGONIST COMPOUNDS, AND COMPOSITIONS AND COMBINATIONS THEREFOR

#19 | 2005-02-10 ✅ Patent 7,018,806 granted on 2006-03-28
US20050032136A1
Physics

Method for identifying endocrine disruptors and kit for carrying out the same

Also check out Otsuka Pharmaceutical Co., Ltd.'s (Osaka, Japan) applicant profile with 3 patent applications submitted.

AssigneeID:

80847 ⎘